Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
April 18, 2024
Achieving the UN Sustainable Development Goals (SDGs) and addressing global challenges will require a step change in private investment in emerging markets and developing economies (EMDEs). Only a small fraction of the trillions in private assets under management are currently directed to EMDEs.
Blog Post
November 28, 2023
The central role that private investors must play in financing Sustainable Development Goals (SDG) investments in emerging markets and developing economies (EMDEs) is now widely understood and acknowledged. The just-published two-volume report of the Independent Experts Group (here and here) to the ...
Blog Post
November 15, 2023
One of the most salient lessons from the pandemic is the need to diversify manufacturing capabilities and bolster supply resilience to avoid a repeat of the slow and inequitable vaccine roll out in African countries. To turn this lesson into action, the Gavi Secretariat is rapidly advancing plans fo...
Blog Post
April 24, 2023
Despite the vivid challenges of the early phase of the COVID-19 pandemic, the world remains unprepared to manufacture and distribute vaccines for the next large health emergency or pandemic. Although the global response to COVID-19 has seen major advances in vaccine technology and distribution, it h...
CGD NOTES
May 11, 2022
This note takes a quick look at the lessons learned and the existing landscape of MCM manufacturing in the context of the current pandemic response and suggests eight areas for action along with near-term recommendations to the global community to both prepare and respond to future pandemic risks.
Blog Post
March 18, 2022
The “billions to trillions” vision advanced the notion that some significant part of official development assistance (ODA) should be used to catalyze additional finance from other public and private sources. Seven years later, the expectations that blended finance would expand sharply to help narrow...
CGD NOTES
March 03, 2022
The COVID-19 pandemic has transformed the global vaccine manufacturing landscape, with capacity more than doubling in the past 18 months. Before the pandemic, manufacturers produced an estimated total of five billion vaccine doses each year. In 2021, manufacturers produced 12 billion doses of C...
Blog Post
February 07, 2022
For those who care about the mobilization of private finance for development, channeling a much larger volume and share of the trillions of dollars of global institutional investment, including from pension funds, into SDG-related investment in emerging markets might be described as the holy grail. ...
Blog Post
October 21, 2021
Poor understanding about vaccine capacity was one of the reasons why the world did not have the infrastructure needed to manufacture sufficient doses. This blogs proposes three actions to start tracking manufacturing capacity better and create robust estimates for the world’s vac...